A Train-the-Trainer Model for Integrating Evidence-Based Medicine Training into Podiatric Medical Education

2005 ◽  
Vol 95 (5) ◽  
pp. 497-504 ◽  
Author(s):  
Michael L. Green

This article presents the development, implementation, and evaluation of a national evidence-based medicine faculty-development program for podiatric medical educators. Ten faculty members representing six accredited colleges of podiatric medicine, one podiatric medical residency program, and a Veterans Affairs podiatry service participated in a 2-day workshop, which included facilitated discussions, minilectures, hands-on exercises, implementation planning, and support after the workshop. Participants’ evidence-based medicine skills were measured by retrospective self-reported ratings before and after the workshop. Participants also reported their implementation of “commitments to change” on follow-up surveys at 3 and 12 months. Participants’ evidence-based medicine practice and teaching skills improved after the intervention. They listed a total of 84 commitments to change, most of which related to the program objectives. By 12 months after the workshop, participants as a group had fully implemented 24 commitments (32%), partially implemented 36 (48%), and failed to implement 15 (20%) of a total of 75 commitments with follow-up data. The most common barriers to change at 12 months were insufficient resources, systems problems, and short patient visit times. A train-the-trainer faculty-development program can improve self-reported evidence-based medicine skills and behaviors and affect curriculum reform at podiatric medical educational institutions. (J Am Podiatr Med Assoc 95(5): 497–504, 2005)

2019 ◽  
pp. 38-55
Author(s):  
Fabrizio Alfani

L'autore, dopo una breve sintesi storica degli approcci teorici alla ricerca in psicoterapia, sottolinea alcuni aspetti problematici della Evidence Based Medicine applicata alla psicoterapia analitica. Vengono inoltre descritti i risultati di alcune ricerche sugli esiti delle terapie analitiche che ne dimostrano l'efficacia, confermata negli studi di follow-up. Vengono infine presentate alcune riflessioni su quale possa essere il ruolo della ricerca empirica nello sviluppo della conoscenza in psicoanalisi e psicologia analitica.


2013 ◽  
Vol 77 (6) ◽  
pp. 716-722 ◽  
Author(s):  
Maureen McAndrew ◽  
Suzanne Motwaly ◽  
Tracy Ellen Kamens

2005 ◽  
Vol 20 (8) ◽  
pp. 721-725 ◽  
Author(s):  
Amy M. Knight ◽  
Karan A. Cole ◽  
David E. Kern ◽  
L. Randol Barker ◽  
Ken Kolodner ◽  
...  

2020 ◽  
Author(s):  
Casey Ankeny ◽  
Lindy Mayled ◽  
Lydia Ross ◽  
Keith Hjelmstad ◽  
Stephen Krause ◽  
...  

Circulation ◽  
2015 ◽  
Vol 132 (suppl_3) ◽  
Author(s):  
Harvey D White ◽  
Ralph A Stewart ◽  
Anthony J Dalby ◽  
Amanda Stebbins ◽  
Christopher P Cannon ◽  
...  

Introduction: Clinical practice guidelines have recommended evidence based medicine (EBM) and treatment targets for optimal management of BP, LDL Cholesterol (LDLc) and of HbA1c in diabetic patients with stable coronary heart disease [CHD]. However the importance of achieving these goals is uncertain. Hypothesis: In patients with stable CHD achievement of goals for blood pressure, LDLc, and HbA1c in diabetics, and use of EBM are associated with a lower risk of major adverse cardiovascular events [MACE]. Methods: In 13,624 patients with stable CHD, who participated in the STabilisation of Atherosclerotic plaque By Initiation of darapLadIb TherapY (STABILITY) trial, BP, LDLc and HbA1c in diabetes were assessed at baseline, and at 3, 6 and 12 month follow-up visits; BP and medication use were additionally assessed at 1 month. EBM; aspirin, beta blockers, ACE / ARB, and statins, were recommended for patients without contraindications. Standard of care (SOC) targets were BP<140/90 mmHg, LDLc <70mg/dl and <100mg/dl, and HbA1c<7% in 4711 diabetics. Achievement of each of these targets was defined as meeting the target on ≥4 of 5 visits for BP and EBM, and ≥3 of 4 biochemical measurements. A landmark analysis assessed the association between achievement of EBM and of each SOC target during the first year of the study and MACE, defined as cardiovascular death, MI, or stroke, during a further 2.7 years follow-up, after adjusting for baseline predictors of MACE in a Cox proportional hazards model. Results: See Table. Conclusions: High rates of evidence based medicine use were achieved. MACE was related to LDLc. After one year the risk of subsequent MACE was reduced for patients who met target LDLc levels and for diabetic patients who achieved target HbA1c.


Sign in / Sign up

Export Citation Format

Share Document